Top Page
Hiscox
(LSE:HSX)
Hiscox (HSX) vs. iShares MSCI United Kingdom ETF (EWC)
Hiscox Business Overview & Revenue Model
Hiscox Earnings Call Summary
Hiscox Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.93B | 3.81B | 3.70B | 2.98B | 3.29B | 3.25B |
| Gross Profit | 3.93B | 3.81B | 3.58B | 2.98B | 3.29B | 3.25B |
| EBITDA | 0.00 | 799.20M | 730.00M | 335.60M | 248.20M | -167.70M |
| Net Income | 595.40M | 627.20M | 712.00M | 253.90M | 189.50M | -293.70M |
Balance Sheet | ||||||
| Total Assets | 12.34B | 11.24B | 11.06B | 13.72B | 13.85B | 13.86B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.23B | 1.47B | 1.40B | 1.35B | 1.64B |
| Total Debt | 856.60M | 743.00M | 754.20M | 635.90M | 746.50M | 946.10M |
| Total Liabilities | 8.53B | 7.55B | 7.76B | 11.31B | 11.31B | 11.50B |
| Stockholders Equity | 3.81B | 3.69B | 3.30B | 2.42B | 2.54B | 2.35B |
Cash Flow | ||||||
| Free Cash Flow | 55.00M | 75.30M | 188.40M | 352.50M | -42.30M | -188.60M |
| Operating Cash Flow | 59.30M | 114.40M | 232.10M | 373.40M | 16.60M | -117.10M |
| Investing Cash Flow | -43.90M | -38.50M | -34.20M | -81.90M | -36.60M | -52.70M |
| Financing Cash Flow | -123.20M | -282.60M | -128.90M | -190.90M | -246.20M | 592.80M |
Hiscox Technical Analysis
Hiscox Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £6.63B | 9.39 | 22.59% | 2.99% | 6.00% | -24.29% | |
76 Outperform | £1.55B | 8.34 | 15.18% | 11.03% | 8.78% | -38.83% | |
75 Outperform | £321.48M | 8.20 | 16.39% | 4.89% | 7.77% | 35.65% | |
74 Outperform | £9.42B | 10.92 | 65.36% | 7.42% | 22.62% | 106.27% | |
71 Outperform | £4.83B | 10.96 | 16.60% | 1.93% | 1.12% | -18.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | £581.96M | -15.34 | -76.14% | ― | -35.05% | 74.73% |
Hiscox Corporate Events
Hiscox Ltd has reported that as of 31 December 2025 its issued ordinary share capital comprised 332,375,257 ordinary shares of 6.5p each, of which 7,523,190 are held in treasury. After excluding treasury shares, the company confirmed that the total number of voting rights stands at 324,852,067, a key reference figure shareholders must use when assessing whether they are required to disclose holdings or changes in their interests under applicable transparency rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has continued to execute its previously announced share buyback programme, repurchasing 99,191 ordinary shares on 19 December 2025 through Citigroup Global Markets at a volume-weighted average price of 1,428.42 pence. The shares, acquired solely on the London Stock Exchange within a narrow intraday price range of 1,422–1,431 pence, will be cancelled, modestly reducing the company’s share capital and enhancing capital return to shareholders as part of its ongoing capital management strategy.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox has completed its previously announced share repurchase programme, buying back a total of 15,894,323 ordinary shares for $275 million between 27 February and 19 December 2025. The programme, executed in two tranches through Peel Hunt and Citigroup, was initially set at $175 million and later increased to $275 million, signalling management’s confidence in the group’s capital position and long‑term prospects while returning substantial capital to shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox has continued to execute its previously announced share buyback programme, repurchasing 190,000 ordinary shares on 18 December 2025 via Citigroup Global Markets at a volume-weighted average price of 1,417.22 pence, within a range of 1,413.00 to 1,421.00 pence. The company will cancel the repurchased shares, modestly reducing its share count and potentially enhancing earnings per share, underscoring ongoing capital management efforts and signalling confidence in its balance sheet and long-term prospects for shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 161,200 of its Ordinary Shares at an average price of 1,416.78 GBp on December 17, 2025. This move demonstrates the company’s commitment to optimizing shareholder value, and the purchased shares will be canceled, potentially signaling confidence in its financial position and strategy.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 160,762 of its own ordinary shares through Citigroup Global Markets Limited. The buyback, part of a previously announced program, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 161,200 of its own ordinary shares as part of its share buyback program. The shares were bought at prices ranging from 1,359.00 GBp to 1,390.00 GBp and will be cancelled, indicating a strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. This strategic move, executed through Citigroup Global Markets Limited, is aimed at enhancing shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of a share buyback program. This move, executed through Citigroup Global Markets Limited, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company engaged in a share buyback programme, announced the purchase of 169,917 ordinary shares at a volume weighted average price of 1,314.77 GBp per share. This transaction, executed through Citigroup Global Markets Limited, is part of their ongoing strategy to manage capital and potentially enhance shareholder value by reducing the number of outstanding shares. The purchased shares will be cancelled, which may impact the company’s earnings per share positively and reflect a commitment to returning value to shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 ordinary shares as part of its ongoing share buyback program. The shares were acquired at a volume-weighted average price of 1,320.05 GBp and will be cancelled. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, reflecting confidence in its financial stability and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced transactions involving its Chief Financial Officer, Paul Cooper, and Chief Underwriting Officer, Joanne Musselle, under the Hiscox UK Sharesave Plan. Paul Cooper acquired 2,452 shares, while Joanne Musselle acquired 2,380 shares and further subscribed to additional shares through the company’s scrip dividend alternative. These transactions reflect the company’s ongoing commitment to employee investment and engagement, potentially enhancing stakeholder confidence in its leadership and strategic direction.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 ordinary shares as part of its share buyback program, with the highest price paid per share being 1,321 GBp and the lowest at 1,306 GBp. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning by signaling confidence in its financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company engaged in the insurance industry, announced a transaction involving the repurchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were purchased at prices ranging from 1,307.00 GBp to 1,322.00 GBp, with a volume-weighted average price of 1,316.45 GBp. This move is part of Hiscox’s strategy to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1453.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 169,810 of its own ordinary shares at prices ranging from 1,307.00 GBp to 1,325.00 GBp, with a volume-weighted average price of 1,319.76 GBp. The repurchased shares will be canceled, which is expected to enhance shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback program, with the highest price paid per share being 1,323 GBp and the lowest 1,301 GBp. This strategic move to repurchase shares is likely aimed at enhancing shareholder value and optimizing the company’s capital structure, reflecting positively on its market confidence and potentially impacting its stock performance.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 ordinary shares at prices ranging from 1,313.00 GBp to 1,326.00 GBp, with an average price of 1,319.27 GBp. This move is part of a strategic initiative to optimize the company’s capital structure and enhance shareholder value, reflecting confidence in its financial health and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its own ordinary shares through Citigroup Global Markets Limited. The shares were bought at prices ranging from 1,326.00 GBp to 1,337.00 GBp, with a volume-weighted average price of 1,331.11 GBp. This move is part of Hiscox’s ongoing strategy to manage its capital structure and enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its total voting rights as of November 28, 2025, with an issued ordinary share capital of 335,584,387 shares, of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 328,061,197 voting rights, which shareholders can use as a reference for calculating their interests under the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the repurchase of 167,862 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at a volume-weighted average price of 1,341.26 GBp and will be canceled, potentially impacting the company’s share capital structure and signaling confidence in its financial position.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its ordinary shares at prices ranging from 1,330.00 GBp to 1,346.00 GBp, with a volume-weighted average price of 1,340.72 GBp. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares outstanding, which may positively impact its share price and earnings per share.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 170,000 ordinary shares as part of its ongoing share buyback program. The shares were acquired at a volume-weighted average price of 1,327.84 pence per share and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its ordinary shares at prices ranging from 1,295.00 GBp to 1,327.00 GBp. This move is part of a strategic initiative to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback program, with the highest price paid per share being 1,330 GBp and the lowest at 1,318 GBp. This move is part of the company’s strategy to enhance shareholder value by reducing the number of outstanding shares, which can potentially increase earnings per share and improve market perception.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback transaction, purchasing 169,758 of its own ordinary shares at a volume-weighted average price of 1,331.92 GBp. This move, part of a previously announced buyback program, is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback, purchasing 170,000 of its own ordinary shares at a volume-weighted average price of 1,329.68 GBp per share. This move is part of the company’s ongoing buyback program, which aims to enhance shareholder value by reducing the number of shares in circulation. The cancellation of these shares is expected to positively impact the company’s earnings per share and is indicative of Hiscox’s confidence in its financial stability and future growth prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 ordinary shares at a volume-weighted average price of 1,339.27 GBp per share. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback program. The shares were bought at prices ranging from 1,328.00 GBp to 1,341.00 GBp and will be cancelled, which is part of a strategic move to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,328.00 GBp to 1,341.00 GBp, with a volume-weighted average price of 1,337.15 GBp. This move is part of Hiscox’s strategy to manage its capital structure and return value to shareholders by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback programme, with the highest price paid per share being 1,366.00 GBp and the lowest at 1,349.00 GBp. This move is part of Hiscox’s strategic financial management, potentially enhancing shareholder value by reducing the number of shares in circulation, which can lead to an increase in earnings per share and a stronger market position.
The most recent analyst rating on (GB:HSX) stock is a Sell with a £1068.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company engaged in a share buyback program, has announced the purchase of 170,000 of its own ordinary shares, with prices ranging from 1,351.00 GBp to 1,367.00 GBp. The shares were acquired through Citigroup Global Markets Limited and will be subsequently cancelled, which is part of a strategic effort to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Sell with a £1068.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 1,366.00 GBp to 1,384.00 GBp, with a volume-weighted average price of 1,372.91 GBp. This move is part of Hiscox’s strategy to enhance shareholder value by reducing the number of shares in circulation, which can potentially increase earnings per share and improve the company’s market position.
The most recent analyst rating on (GB:HSX) stock is a Sell with a £1068.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback program, initially announced on October 6, 2025. The shares were acquired at a volume-weighted average price of 1,369.79 pence per share and will be canceled, reflecting the company’s strategy to return value to shareholders and optimize its capital structure.
The most recent analyst rating on (GB:HSX) stock is a Sell with a £1068.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 170,000 of its own ordinary shares as part of a share buyback program initiated on October 6, 2025. The shares were acquired at a volume-weighted average price of 1,388.63 GBp and will be canceled, potentially impacting the company’s share value and benefiting shareholders by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Sell with a £1068.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced a significant transaction involving the repurchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. This move, executed through Citigroup Global Markets Limited, is part of the company’s strategy to enhance shareholder value by reducing the number of outstanding shares, potentially increasing earnings per share and demonstrating confidence in its financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the current estimates for its Syndicate 33 and Syndicate 6104 for the 2023 and 2024 accounts. The estimates for Syndicate 33 remain stable for 2023, while there is a slight increase in the range for 2024. Syndicate 6104 shows an increase in estimates for both years, indicating a positive outlook for the company’s operations. These adjustments reflect Hiscox’s strategic positioning in the insurance market, potentially impacting stakeholders by showcasing the company’s resilience and growth potential.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 169,864 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired through Citigroup Global Markets Limited and will be cancelled, reflecting the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its ordinary shares at prices ranging from 1,325.00 GBp to 1,356.00 GBp. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares outstanding, which can potentially increase earnings per share and improve market perception.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of a share buyback program initiated in October 2025. The shares were acquired at a volume-weighted average price of 1,366.06 GBp and will be cancelled, which is a strategic move to potentially enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd reported a 5.9% increase in group insurance contract written premiums for the first nine months of 2025, with strong growth across its retail, London Market, and reinsurance segments. The company is on track to achieve over 6% growth in its retail segment, driven by distribution momentum, new broker deals, and technological advancements. Hiscox has also made significant progress in its change program and share buyback initiative, enhancing its market position and capital generation capabilities. The company’s strategic focus on disciplined capital deployment and product innovation is helping it navigate competitive pressures, particularly in the property and casualty markets.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 160,000 of its own ordinary shares as part of its share buyback program, which was initiated to enhance shareholder value. The shares were bought at prices ranging from 1,336.00 GBp to 1,358.00 GBp and will be cancelled, reflecting the company’s commitment to optimizing its capital structure and potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 160,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,366.00 GBp to 1,384.00 GBp, with a volume-weighted average price of 1,373.40 GBp. This move is part of Hiscox’s strategy to optimize its capital structure and enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and supporting the share price.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its total voting rights as of October 31, 2025, reporting an issued ordinary share capital of 338,685,954 shares, with 7,523,190 held in treasury. This results in a total of 331,162,764 voting rights, which shareholders can use to assess their interests under the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company involved in the insurance industry, has announced a significant transaction under its share buyback programme. The company purchased 160,000 of its own ordinary shares at prices ranging from 1,372.00 GBp to 1,409.00 GBp, with a volume-weighted average price of 1,385.85 GBp. These shares will be cancelled, which is part of their strategy to manage capital and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 160,000 of its own ordinary shares through Citigroup Global Markets Limited. The shares were bought at a volume-weighted average price of 1,397.76 GBp and will be canceled, which is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 89,000 of its own ordinary shares as part of a share buyback program. The shares were bought at prices ranging from 1,374.00 GBp to 1,402.00 GBp, with a volume-weighted average price of 1,385.55 GBp. This move is part of the company’s strategy to return value to shareholders and optimize its capital structure, potentially impacting its stock value and investor confidence.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 89,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,387.00 GBp to 1,402.00 GBp and will be cancelled. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, reflecting confidence in the company’s financial health and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 89,000 of its own ordinary shares as part of its share buyback program, with the highest price paid per share being 1,384.00 GBp and the lowest at 1,372.00 GBp. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and signaling confidence in its financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 89,000 ordinary shares through Citigroup Global Markets Limited, with the highest price paid per share being 1,376.00 GBp and the lowest at 1,365.00 GBp. This strategic move is part of the company’s ongoing efforts to manage its capital structure, potentially enhancing shareholder value and demonstrating confidence in its financial stability.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 87,840 of its own ordinary shares through Citigroup Global Markets Limited. The shares were bought at prices ranging from 1,344.00 GBp to 1,373.00 GBp and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.